Here are relevant reports on : education-administration-market
-
IoT in Education Market by Component (Hardware, Solutions & Services), End User (Academic Institutions & Corporates), Application (Learning Management, Classroom Management, Administration Management & Surveillance), and Region - Global Forecast to 2023
The global IoT in education market size is expected to grow from USD 4.8 billion in 2018 to USD 11.3 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 18.8% during the forecast period. Major growth factors for the IoT in education market include an increased use of connected devices in the education institutions, rapid adoption of eLearning, and availability of cloud-based solution. Major vendors covered in the IoT in education market include Google (US), Amazon Web Services (US), IBM (US), Microsoft (US), Oracle (US), Intel (US), Cisco (US), SAP (Germany), Huawei (China), Arm (UK), Unit4 (Netherlands), and Samsung (South Korea).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
IV Equipment Market by Type (IV Catheter, IV Administration Set, Needle-free Connectors), Application (Medication Administration, Parenteral Nutrition, Diagnostic Testing, Blood & Blood Product Transfusion), End User (Hospital) - Global Forecast to 2031
The IV Equipment market, valued at US$16.85 billion in 2025, stood at US$17.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2031, culminating in a forecasted valuation of US$23.92 billion by the end of the period. The IV equipment market is expected to grow significantly, driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) - Global Forecast 2022
The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Education ERP Market by Component (Software, Services), Deployment Type, End User (K-12, Higher Education), Application (Student Management, Academic Management, Finance & Accounting Management), Region - Global Forecast to 2026
The Education ERP Market was reached at USD 12.7 billion in 2021 and expected to grow USD 25.2 billion by 2026, at a CAGR of 14.7% during the forecast period. Key and innovative vendors in the education ERP market include Anubavam (US), Blackbaud (US), Brainvire (US), Edumarshal (India), Ellucian (US), Entab (India), Focus Softnet (UAE), Foradian (India), Infor (US), Jenzabar (US), LIBSYS (India), Lighthouse Info Systems (India), Microsoft (US), Oracle (US), Prolitus (India), Ramco Systems (India), Sage (UK), SAP (Germany), Serosoft (India), Skolaro (India), Sparkrock (US), TCS (India), Tyler Technologies (US), Unit4 (Netherlands), and Workday (US).
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Asia Pacific Enteral Feeding Devices Market, by Type (Administration sets, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Respiratory), End User - Forecast to 2032
The Asia Pacific enteral feeding device market, valued at USD 0.76 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2032, culminating in a forecasted valuation of USD 1.20 billion by the end of the period. In the Asia Pacific enteral feeding devices market, the growth of enteral feeding tubes is primarily attributed to the incidence of diseases such as cancer, stroke, neurological disorders, and gastrointestinal diseases that often lead to swallowing difficulties and require prolonged nutrition support.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pain Patch Market by Type (Opioid & Non-Opioid), By Mode of Administration (Metered Dose & Microneedle Patches) and by Therapeutic Use (Pain relief, Anaesthesia, Cough Suppression, Smoking Cessation) - Global Forecast to 2023
The global Pain Patch market is expected to reach USD 30.95 billion by 2023 from USD 24.25 billion in 2018, growing at a CAGR of 5.0%. Rising usage of opioids in non-cancer conditions and favourable reimbursement policies, increasing research and development in this field, favourable reimbursement facilities for palliative care in North American and European countries are some factors also promoting growth.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Identity and Access Management (IAM) Market by Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type (Workforce, CIAM, B2B), Identity Type (Human, Non-Human Identity) - Forecast to 2030
The size of the identity and access management (IAM) market in Europe is projected to grow from USD 6.09 billion in 2025 to USD 9.79 billion by 2030 at a CAGR of 10.0% during the forecast period. The Key Players Microsoft (US), Thales (France), Evidian (France), Ping Identity (US), IBM (US), Okta (US), Oracle (US), iC Consult (Germany), IN Groupe (France), Ubisecure (Finland), CyberArk (US), HID Global (US), Authentik (US), cidaas (Germany), Curity (Sweden), Traxion (Netherlands), Elimity (Belgium), and Omada (Denmark)
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Companion Animal Pharmaceuticals Market by Animal Type (Dogs, Cats, Horses), Route of Administration (Oral, Injectable, Topical), Indication (Antibiotics, Parasiticides), Distribution Channel (Veterinary Hospitals & Clinics) & Region - Global Forecasts to 2027
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The Asia Pacific injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period. The growth of the Asia Pacific injectable drug delivery market is driven by the increasing incorporation of biologics, biosimilars, and long-acting injectables, alongside a rapidly growing patient population and an escalating burden of chronic diseases across major countries in the region.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
